Lightship, a virtual-first provider of clinical trials, today announced that it has raised $40 million to create access to clinical research for all patients, and improve diversity among patient groups taking part in clinical trials around the world.
The funding round was led by Define Ventures and Brook Byers, with participation from Khosla Ventures, McKesson Ventures, and Marc Benioff’s TIME Ventures. These new funds will be used to help drive the firm’s expansion, including internationally, with a new office opening in the fall in London, United Kingdom.
Lightship has also created several senior roles. Co-founder Samantha Eells is taking up the role of chief client officer. Jean Holder is moving into the newly created role of chief operating officer, and Sarah Firman has been appointed chief people officer. Rachel Scott will be leading Lightship’s growth and expansion as executive vice president, head of expansion. Beverly Rubin remains Lightship’s general counsel.
“Today, only a small proportion of the global patient population has access to clinical trials as a treatment option. This new investment, plus the expansion of our team, enables Lightship to grow internationally and continue our journey to give patients everywhere the opportunity to participate in clinical research,” said Lightship CEO David MacMurchy. “This is such an exciting, fast-growing market, and at Lightship we have amazing teams committed to our mission and going beyond expectations for patients and sponsors of clinical studies.”
“We’ve seen outstanding growth and progress in decentralized clinical trials and there’s huge potential for more innovation in the U.S. and other markets,” said Dave Schulte, senior vice president and managing director of McKesson Ventures. “We’re proud to back Lightship’s expansion and this team’s relentless commitment to delivering successful clinical trials and the support it provides sponsors and patients at every step.”
Read the full press release on BusinessWire.